A Erhardt

Summary

Affiliation: Heinrich Heine University
Country: Germany

Publications

  1. ncbi Response to antiviral treatment in patients infected with hepatitis B virus genotypes E-H
    Andreas Erhardt
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Heinrich Heine Universitat Dusseldorf, Dusseldorf, Germany
    J Med Virol 81:1716-20. 2009
  2. ncbi [Iron as comorbid factor in chronic hepatitis C]
    Andreas Erhardt
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Heinrich Heine Universitat, Dusseldorf
    Med Klin (Munich) 98:685-91. 2003
  3. ncbi [Transient elastography for diagnosing liver cirrhosis]
    A Erhardt
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Heinrich Heine Universitat, Dusseldorf
    Dtsch Med Wochenschr 131:2765-9. 2006
  4. ncbi HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis
    Andreas Erhardt
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Heinrich Heine Universitat Dusseldorf, Moorenstrasse 5, 40225 Dusseldorf, Germany
    J Hepatol 38:335-42. 2003
  5. ncbi [Update hepatitis D]
    Andreas Erhardt
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Heinrich Heine Universitat Dusseldorf
    Med Klin (Munich) 101:127-34. 2006
  6. ncbi [Hepatocellular carcinoma: rising incidence of hepatitis C virus-associated cases at a university clinic in Germany]
    A Erhardt
    Klinik fur Gastroenterologie, Hepatologie und Infektiologiem, Germany
    Dtsch Med Wochenschr 127:2665-8. 2002
  7. ncbi Treatment of chronic hepatitis delta with pegylated interferon-alpha2b
    Andreas Erhardt
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinikum der Heinrich Heine Universität Düsseldorf, Dusseldorf, Germany
    Liver Int 26:805-10. 2006
  8. ncbi HFE mutations in idiopathic dilated cardiomyopathy
    Andreas Erhardt
    Department of Gastroenterology, Hepatology and Infectiology, Heinrich Heine University Duesseldorf, Germany
    Med Klin (Munich) 101:135-8. 2006
  9. ncbi Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D
    A Erhardt
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Heinrich Heine Universitat Dusseldorf, Moorenstr 5, D 40225 Dusseldorf, Germany
    Gut 54:1009-13. 2005
  10. ncbi Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line
    Andreas Erhardt
    Klinik fur Gastroenterologie, Hepatologie, und Infektiologie, Heinrich Heine Universitat Dusseldorf, Moorenstrasse 5, D 40225 Dusseldorf, Germany
    Virology 292:272-84. 2002

Detail Information

Publications49

  1. ncbi Response to antiviral treatment in patients infected with hepatitis B virus genotypes E-H
    Andreas Erhardt
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Heinrich Heine Universitat Dusseldorf, Dusseldorf, Germany
    J Med Virol 81:1716-20. 2009
    ..Lower rates of response to IFN-alpha in patients with HBV genotype G might be related to the frequent occurrence of double infection...
  2. ncbi [Iron as comorbid factor in chronic hepatitis C]
    Andreas Erhardt
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Heinrich Heine Universitat, Dusseldorf
    Med Klin (Munich) 98:685-91. 2003
    ..Thus, HFE mutations and liver iron stores seem to be important comorbid factors in chronic hepatitis C. Screening for iron parameters and HFE mutations should be considered in patients with hepatitis C...
  3. ncbi [Transient elastography for diagnosing liver cirrhosis]
    A Erhardt
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Heinrich Heine Universitat, Dusseldorf
    Dtsch Med Wochenschr 131:2765-9. 2006
    ..Detection of liver cirrhosis has numerous implications because of the potential sequelae of cirrhosis. Transient elastography (Fibroscan), was evaluated as a novel, non-invasive means of assessing cirrhosis by measuring liver stiffness...
  4. ncbi HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis
    Andreas Erhardt
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Heinrich Heine Universitat Dusseldorf, Moorenstrasse 5, 40225 Dusseldorf, Germany
    J Hepatol 38:335-42. 2003
    ..The impact of heterozygous HFE mutations on the course of chronic hepatitis C and iron indices was studied...
  5. ncbi [Update hepatitis D]
    Andreas Erhardt
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Heinrich Heine Universitat Dusseldorf
    Med Klin (Munich) 101:127-34. 2006
    ..Pegylated interferons, a prolongation of treatment beyond 12 months, combination therapies with ribavirin and prenylation inhibitors are possibly new therapeutic options in chronic hepatitis C...
  6. ncbi [Hepatocellular carcinoma: rising incidence of hepatitis C virus-associated cases at a university clinic in Germany]
    A Erhardt
    Klinik fur Gastroenterologie, Hepatologie und Infektiologiem, Germany
    Dtsch Med Wochenschr 127:2665-8. 2002
    ..The aim of the present, retrospective study was to determine changes in the incidence rates and risk factors for HCC in Germany based on the data of a single center...
  7. ncbi Treatment of chronic hepatitis delta with pegylated interferon-alpha2b
    Andreas Erhardt
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinikum der Heinrich Heine Universität Düsseldorf, Dusseldorf, Germany
    Liver Int 26:805-10. 2006
    ..Chronic hepatitis D is difficult to treat. The present pilot study investigated the efficacy and tolerability of pegylated (PEG)-interferon (IFN)-alpha2b in chronic hepatitis D...
  8. ncbi HFE mutations in idiopathic dilated cardiomyopathy
    Andreas Erhardt
    Department of Gastroenterology, Hepatology and Infectiology, Heinrich Heine University Duesseldorf, Germany
    Med Klin (Munich) 101:135-8. 2006
    ..The present study investigated, whether mutations of the hemochromatosis (HFE) gene might be etiologic and disease-modifying factors in idiopathic dilated cardiomyopathy..
  9. ncbi Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D
    A Erhardt
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Heinrich Heine Universitat Dusseldorf, Moorenstr 5, D 40225 Dusseldorf, Germany
    Gut 54:1009-13. 2005
    ..Current interferon alfa (IFN) treatment of chronic hepatitis B has limited efficacy. The role of hepatitis B virus (HBV) genotypes for response to IFN was investigated...
  10. ncbi Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line
    Andreas Erhardt
    Klinik fur Gastroenterologie, Hepatologie, und Infektiologie, Heinrich Heine Universitat Dusseldorf, Moorenstrasse 5, D 40225 Dusseldorf, Germany
    Virology 292:272-84. 2002
    ..This was accompanied by an activation of c-Jun and ATF-2, but not Elk-1 and c-Fos. Furthermore, AP-1 activation was independent of c-Fos. Full-length and N(c)-truncated HCV core proteins exerted similar effects...
  11. ncbi A seropneumothorax?
    Andreas Erhardt
    Department of Internal Medicine, Heinrich Heine Universitat, 40225, Dusseldorf, Germany
    Lancet 359:578. 2002
  12. ncbi Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivudine
    A Erhardt
    Klinik fur Gastroenterologie, Hepatologie und Infektologie, Heinrich Heine University, Dusseldorf Germany
    J Hepatol 33:677-83. 2000
    ..The present protocol of short-term prednisolone administration combined with alpha-interferon and lamivudine was effective for the treatment of HBV-related polyarteritis nodosa and may be a promising new therapeutic approach...
  13. ncbi Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B
    A Erhardt
    Department of Internal Medicine, Division of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich Heine University of Dusseldorf, Dusseldorf, Germany
    Hepatology 31:716-25. 2000
    ..Our data suggest that HBV genome mutations located within the BCP are determinants of a response to IFN therapy...
  14. ncbi Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment
    Andreas Erhardt
    Klinik fur Gastroenterologie, Hepatologie and Infektiologie, Universitätsklinik Düsseldorf, Dusseldorf, Germany
    Antivir Ther 14:23-32. 2009
    ..BILB 1941 is a potent and specific nonnucleoside inhibitor of the hepatitis C virus (HCV) RNA polymerase in vitro...
  15. ncbi Combination therapy of active HBsAg vaccination and interferon-alpha in interferon-alpha nonresponders with chronic hepatitis B
    T Heintges
    Department of Gastroenterology, Hepatology and Infectious Diseases, , Germany
    Dig Dis Sci 46:901-6. 2001
    ..This combination therapy seems to offer a new and promising approach for patients with chronic hepatitis B virus infection...
  16. ncbi [Current treatment of hepatitis C virus infection]
    J Lörke
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Heinrich Heine Universitat, Dusseldorf
    Dtsch Med Wochenschr 130:1773-7. 2005
    ..Because the optimal treatment strategy for patients with an acute hepatitis C infection is still unclear, these patients should be included in clinical studies...
  17. ncbi Trimodal therapy in squamous cell carcinoma of the esophagus
    C Matuschek
    Klinik für Strahlentherapie und Radiologische Onkologie, Heinrich Heine Universitat Dusseldorf, Moorenstr 5, 40225 Dusseldorf, Germany
    Eur J Med Res 16:437-44. 2011
    ..In the future, early response evaluation and molecular biological tests could be important diagnostic tools in influencing the treatment decisions of ESCC patients...
  18. ncbi Therapy outcome in patients with chronic hepatitis C: role of therapy supervision by expert hepatologists
    A Sagir
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinik Düsseldorf, Moorenstr, Dusseldorf, Germany
    J Viral Hepat 14:633-8. 2007
    ..015). Patients with unfavourable genotypes 1 and 4 or with advanced liver damage benefit from HCV therapy supervision by a specialist, probably because of less frequent treatment interruptions or dose reductions...
  19. ncbi Prognosis of chronic hepatitis C: results of a large, prospective cohort study
    C Niederau
    Department of Medicine, Division of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich Heine Universitat Dusseldorf, Dusseldorf, Germany
    Hepatology 28:1687-95. 1998
    ..The age at diagnosis therefore should play a major role in therapeutic considerations. The present data also suggest that interferon therapy has a long-term clinical benefit, although it did not reduce the risk of liver cancer...
  20. ncbi Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis
    Kalliopi Zachou
    Department of Gastroenterology, Hepatology and Endocrinology, Hanover Medical School, Hanover, Germany
    Liver Int 30:430-7. 2010
    ..ii) Biochemical parameters did not accurately indicate the stage and grade of liver disease in chronic HDV and thus liver biopsy seems to remain the major tool for the evaluation of delta hepatitis patients...
  21. ncbi Combination treatment of IFNalpha2b and ribavirin in patients with chronic hepatitis C and persistently normal ALTs
    Andreas Erhardt
    , Hepatologie und Infektiologie, , , Germany
    Dig Dis Sci 48:921-5. 2003
    ..Treatment was discontinued in 3 patients due to side effects. Interferon (IFN) ribavirin combination therapy is effective in patients with normal ALTs and appears superior to IFN monotherapy...
  22. ncbi [Increasing number and improved survival of patients with hepatocellular carcinoma from 1988 to 2007: data of a German university clinic]
    A Erhardt
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Heinrich Heine Universitat Dusseldorf
    Z Gastroenterol 49:720-7. 2011
    ..The aim of the present study was to determine changes of clinical-epidemiological parameters and survival rates during two decades...
  23. ncbi Do insulin-like growth factor associated proteins qualify as a tumor marker? Results of a prospective study in 163 cancer patients
    C Matuschek
    Department of Radiation Therapy and Radiooncology, Universitatsklinikum Dusseldorf, Heinrich Heine Universitat, Duesseldorf, Germany
    Eur J Med Res 16:451-6. 2011
    ..It has never been evaluated, if the IGF-system can serve as a tumor marker in neoplasms...
  24. ncbi Renal function during treatment with adefovir plus peginterferon alfa-2a vs either drug alone in hepatitis B/D co-infection
    I Mederacke
    Department of Gastroenterology, Hannover Medical School, Hannover, Germany
    J Viral Hepat 19:387-95. 2012
    ..Combination treatment of PegIFNα-2a+ADV in chronic hepatitis B/D co-infection did not lead to any further impairment of kidney function...
  25. ncbi [HIV-HBV-coinfection--diagnosis and therapy]
    S Koch
    , Hepatologie und Infektiologie, , Moorenstrasse 5,
    Dtsch Med Wochenschr 131:1873-7. 2006
  26. ncbi Sunitinib induced pyoderma gangrenosum-like ulcerations
    S Akanay-Diesel
    Universitatsklinikum Dusseldorf, Heinrich Heine Universitat, Duesseldorf, Germany
    Eur J Med Res 16:491-4. 2011
    ..Here, we demonstrate that pyoderma gangrenosum-like ulcers may represent a serious side effect of sunitinib-based anti-cancer treatment...
  27. ncbi Induction of autoimmune hepatitis by pegylated interferon alfa-2b in chronic hepatitis C
    Julia Lörke
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Heinrich Heine Universitat, Dusseldorf, Germany
    Clin Gastroenterol Hepatol 2:xx. 2004
  28. ncbi Cholestatic liver diseases from child to adult: the diversity of MDR3 disease
    R Kubitz
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Universitatsklinikum Dusseldorf
    Z Gastroenterol 49:728-36. 2011
    ..Even the same mutation may be associated with varying disease progression...
  29. ncbi Retrospective analysis of chronic hepatitis D in a West German University Clinic over two decades: migratory pattern, prevalence and clinical outcome
    A Erhardt
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinikum der Heinrich Heine Universität Düsseldorf
    Z Gastroenterol 48:813-7. 2010
    ..Epidemiology, clinical features and long term-course of chronic hepatitis D were addressed in a non-endemic Central European area...
  30. ncbi [Diagnosis of focal liver lesions in cirrhotic patients: comparison of contrast-enhanced ultrasound using sulphur hexafluoride (SF6) microbubbles and MRI using Gd-EOB-DTPA]
    D Blondin
    Institut fur Radiologie, Heinrich Heine Universitat Dusseldorf
    Z Gastroenterol 49:23-9. 2011
    ..The diagnostic accuracies of contrast-enhanced sonography and hepatobiliary contrast-enhanced MRI of the liver in evaluating focal liver lesions in patients with liver cirrhosis were compared...
  31. ncbi Plasma levels of vitamin E and carotenoids are decreased in patients with Nonalcoholic Steatohepatitis (NASH)
    Andreas Erhardt
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Heinrich Heine Universitat Dusseldorf, Moorenstr 5, 40225 Dusseldorf, Germany
    Eur J Med Res 16:76-8. 2011
    ..Oxidative stress is suggested to play an important role in the pathogenesis of nonalcoholic steatohepatitis (NASH). The present study was aimed to compare plasma levels of antioxidants in patients suffering from NASH and healthy controls...
  32. ncbi Relapse to prior therapy is the most important factor for the retreatment response in patients with chronic hepatitis C virus infection
    Abdurrahman Sagir
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinik Düsseldorf, Dusseldorf, Germany
    Liver Int 27:954-9. 2007
    ..In this report, we investigated response rates to combination therapy [standard IFN-alpha or PEG-IFN-alpha and ribavirin] in patients who relapsed or failed in prior therapy...
  33. ncbi SEN virus does not affect treatment response in hepatitis C virus coinfected patients but SEN virus response depends on SEN virus DNA concentration
    Abdurrahman Sagir
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Universitatsklinikum Dusseldorf, Moorenstrasse 5, 40225 Dusseldorf, Germany
    World J Gastroenterol 10:1893-7. 2004
    ..To clarify the effect of SEN virus (SENV) infection on a combination therapy including interferon alfa (IFN-alpha) or pegylated-IFN with ribavirin in patients with chronic hepatitis and the effect of a combination therapy on SENV...
  34. ncbi SEN virus seroprevalence in HIV positive patients: association with immunosuppression and HIV-replication
    Abdurrahman Sagir
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, der Universitätsklinik Düsseldorf, Moorenstr 5, 40225 Dusseldorf, Germany
    J Clin Virol 33:183-7. 2005
    ..The results were correlated with clinical markers such as HIV stage, CD4 cell count, HIV-RNA positivity, HAART or the transmission mode in HIV infected individuals...
  35. ncbi SEN virus has an adverse effect on the survival of HIV-positive patients
    Abdurrahman Sagir
    Clinic for Gastroenterology, Hepatology and Infections bInstitute of Virology, University of Dusseldorf, Dusseldorf, Germany
    AIDS 19:1091-6. 2005
    ..Patients infected with HIV are often coinfected with other viruses...
  36. ncbi The German guideline for the management of hepatitis B virus infection: short version
    M Cornberg
    Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
    J Viral Hepat 15:1-21. 2008
  37. ncbi SEN virus infection
    Abdurrahman Sagir
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinik Düsseldorf, Moorenstr 5, 40225 Dusseldorf, Germany
    Rev Med Virol 14:141-8. 2004
    ..Data for other acute and chronic liver diseases are sparse. Further studies are needed to define the pathogenesis and clinical importance of SEN-V infection...
  38. ncbi New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples
    Thomas Göbel
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Heinrich Heine Universitat Dusseldorf, Moorenstr 5, D 40225 Dusseldorf, Germany
    World J Gastroenterol 12:7604-12. 2006
    ....
  39. ncbi The role of neoadjuvant and adjuvant treatment for adenocarcinoma of the upper gastrointestinal tract
    C Matuschek
    Klinik für Strahlentherapie und Radiologische Onkologie, Heinrich Heine Universitat Dusseldorf, Germany
    Eur J Med Res 16:265-74. 2011
    ..In addition, there are no standard recommendations for adjuvant chemotherapy or chemoradiation after R0 resection and adequate lymph node dissection...
  40. ncbi IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3
    Johannes G Bode
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Medizinische Klinik der Heinrich Heine Universität, 40255 Düsseldorf, Germany
    FASEB J 17:488-90. 2003
    ..These IFN-antagonistic properties of the HCV core protein may be part of the molecular basis of IFN-alpha unresponsiveness in about one-half of chronically infected HCV-patients...
  41. ncbi Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage
    Abdurrahman Sagir
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinik Düsseldorf, Dusseldorf, Germany
    Hepatology 47:592-5. 2008
    ..CONCLUSION: Transient elastography frequently yields pathologically high values in patients with acute liver damage and is unsuitable for detecting cirrhosis/fibrosis in these patients...
  42. ncbi Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase
    Erwin Daniel Brenndörfer
    Department of Gastroenterology, Hepatology and Infectiology, University Hospital, Heinrich Heine University of Dusseldorf, Germany
    Hepatology 49:1810-20. 2009
    ..Hence, therapeutic targeting of NS3/4A may not only disturb viral replication by blocking the processing of the viral polyprotein but also exerts unforeseen indirect antiviral effects, further diminishing viral replication...
  43. ncbi Cloning and molecular characterization of human high affinity antibody fragments against Hepatitis C virus NS3 helicase
    Kathi Tessmann
    Department of Gastroenterology, Hepatology and Infectious Diseases, Heinrich-Heine-University, Moorenstr. 5, 40225, , Germany
    J Virol Methods 103:75-88. 2002
    ..Employing vectors for transduction of the encoding cDNA into infected cells might be a novel gene therapy strategy for intracellular immunization against chronic HCV infection...
  44. ncbi Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients
    Holger Hinrichsen
    Medizinische Universitatsklinik, Kiel, Germany
    Gastroenterology 127:1347-55. 2004
    ..BILN 2061 is a potent and specific inhibitor of HCV serine protease in vitro. Preclinical toxicology data and studies in healthy volunteers supported the administration of BILN 2061 to patients with HCV infection...
  45. ncbi HFE gene mutations and iron metabolism in Wilson's disease
    Andreas Erhardt
    Klinik fur Gastroenterologie, Hepatologie und Infektiologie des Universitätsklinikums Düsseldorf, Klinik für Neurologie des Universitätsklinikums Düsseldorf
    Liver 22:474-8. 2002
    ..There is increasing evidence for an interaction between iron and copper metabolism...
  46. ncbi Mating frequency influences nectar amino acid preference of Pieris napi
    Jovanne Mevi-Schutz
    Department of Integrative Biology, Section of Conservation Biology NLU, University of Basel, St Johanns Vorstadt 10, CH 4056 Basel, Switzerland
    Proc Biol Sci 271:153-8. 2004
    ..These results indicate a versatile response of females to nectar amino acids, depending on their nutritional status; they may even switch their source of amino acids between adult feeding and nuptial gifts...
  47. ncbi Budesonide-induced acute hepatitis in an HIV-positive patient with ritonavir as a co-medication
    Abdurrahman Sagir
    AIDS 16:1191-2. 2002
  48. ncbi Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide
    Philipp A Lang
    Institute of Physiology University of Tübingen, 72076 Tubingen, Germany
    Nat Med 13:164-70. 2007
    ..Our data suggest a previously unidentified mechanism for liver cirrhosis and anemia in Wilson disease...
  49. ncbi Genotype-specific response of a lycaenid herbivore to elevated carbon dioxide and phosphorus availability in calcareous grassland
    Marcel Goverde
    Department of Integrative Biology, Section of Conservation Biology, University of Basel, St Johanns Vorstadt 10, 4056, Basel, Switzerland
    Oecologia 139:383-91. 2004
    ..As far as we know this is the first finding of a genotype-specific response of an insect herbivore to elevated CO2 which suggests genetic shifts in insect life history traits in response to elevated CO2...